Aurobindo Pharma Ltd.

NSE: AUROPHARMA | BSE: 524804 | ISIN: INE406A01037 | Industry: Pharmaceuticals
| Mid-range Performer
1090.9000 -19.00 (-1.71%)
NSE Sep 24, 2025 15:58 PM
Volume: 1.2M
 

1090.90
-1.71%
Deven Choksey
Aurobindo Pharma’s wholly owned subsidiary, Aurobindo Pharma USA Inc., has entered into a definitive agreement with Lannett Seller Holdco, Inc. to acquire 100% membership interest in Lannett Company LLC.
Aurobindo Pharma Ltd. is trading above its 50 day SMA of 1087.4
More from Aurobindo Pharma Ltd.
Recommended